An expert explained a potential side effect associated with treatment consisting of Itovebi for breast cancer.

A new research paper was published in , Volume 16, on February 18, 2025, titled "Leukopenia, weight loss and oral mucositis induced by 5-Fluorouracil in hamsters' model: A regenerative approach using ...

To our knowledge, this is the first-in-animal preliminary study, which used a biocompatible electrospun membrane with the addition of autologous ...

A new research paper was published in Oncotarget, Volume 16, on February 18, 2025, titled “Leukopenia, weight loss and oral ...

Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or ...

Cancer patients undergoing chemotherapy or radiotherapy often experience 'chemo mouth,' with painful symptoms like mouth ...

Turmeric and honey contain many compounds that may help reduce inflammation, improve inflammation-related conditions, and ...

A new study published in the journal of Clinical Oral Implant Research showed that nonsurgical mechanical debridement with ...

Also, regarding HyBryte (TM), in October 2024, Soligenix announced that the Hong Kong Patent Office had granted the patent entitled "Systems and Methods for Producing Synthetic Hypericin." Synthetic ...

For some, chemo mouth can result in mouth sores and other uncomfortable symptoms, like a limited ability to eat, drink or ...

EQS-News: Benzinga / Key word (s): Science Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And ...

Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, provides new insights on the role of TROP2-directed antibody ...